• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病分期。一种病例组合测量方法。

Staging of disease. A case-mix measurement.

作者信息

Gonnella J S, Hornbrook M C, Louis D Z

出版信息

JAMA. 1984 Feb 3;251(5):637-44.

PMID:6418903
Abstract

Measurement of illness severity is required to evaluate diagnostic efficiency of physicians, assess quality of care, understand utilization of health services, design clinical trials, and reimburse hospitals on the basis of output. "Staging" is a method for measuring severity of specific, well-defined diseases. Staging defines discrete points in the course of individual diseases that are clinically detectable, reflect severity in terms of risk of death or residual impairment, and possess clinical significance for prognosis and choice of therapeutic modality. Medical staging criteria have been developed for 420 diagnoses and converted into "coded" criteria for the major diagnostic coding systems. Coded criteria can be efficiently applied to computerized hospital discharge abstracts to derive a comprehensive case-mix classification system. Uses of staging in epidemiologic, case-mix, and utilization analyses are illustrated for diabetes mellitus.

摘要

为了评估医生的诊断效率、评估医疗质量、了解卫生服务的利用情况、设计临床试验以及根据产出对医院进行报销,需要对疾病严重程度进行测量。“分期”是一种测量特定的、明确界定的疾病严重程度的方法。分期定义了个体疾病过程中临床上可检测到的离散点,这些点反映了死亡风险或残留损伤方面的严重程度,并且对预后和治疗方式的选择具有临床意义。已经为420种诊断制定了医学分期标准,并将其转换为主要诊断编码系统的“编码”标准。编码标准可以有效地应用于计算机化的医院出院摘要,以得出一个全面的病例组合分类系统。文中以糖尿病为例说明了分期在流行病学、病例组合和利用分析中的应用。

相似文献

1
Staging of disease. A case-mix measurement.疾病分期。一种病例组合测量方法。
JAMA. 1984 Feb 3;251(5):637-44.
2
Measuring severity of illness to predict patient resource use within DRGs.测量疾病严重程度以预测诊断相关分组内的患者资源使用情况。
Inquiry. 1983 Winter;20(4):314-21.
3
Variation in patient routine costliness in U.S. psychiatric facilities.美国精神病治疗机构中患者常规费用的差异。
J Ment Health Policy Econ. 2005 Mar;8(1):15-28.
4
Clinical redesign using all patient refined diagnosis related groups.使用所有患者细化诊断相关组进行临床重新设计。
Pediatrics. 2004 Oct;114(4):965-9. doi: 10.1542/peds.2004-0650.
5
Measuring case mix and severity of illness in Canada: case mix groups versus refined diagnosis related groups.
Healthc Manage Forum. 1993 Winter;6(4):20-6. doi: 10.1016/S0840-4704(10)61131-3.
6
Coding response to a case-mix measurement system based on multiple diagnoses.基于多重诊断的病例组合测量系统的编码响应
Health Serv Res. 2004 Aug;39(4 Pt 1):1027-45. doi: 10.1111/j.1475-6773.2004.00270.x.
7
Disease staging: implications for hospital reimbursement and management.疾病分期:对医院报销和管理的影响。
Health Care Financ Rev. 1984;Suppl(Suppl):13-22.
8
Case-mix differences between teaching and nonteaching hospitals.教学医院与非教学医院之间的病例组合差异。
Inquiry. 1987 Spring;24(1):68-84.
9
Incorporating severity of illness and comorbidity in case-mix measurement.在病例组合测量中纳入疾病严重程度和合并症。
Health Care Financ Rev. 1984;Suppl(Suppl):23-31.
10
1997 summary: National Hospital Discharge Survey.1997年总结:国家医院出院调查
Adv Data. 1999 Aug 18(308):1-16.

引用本文的文献

1
Plasma tau biomarkers for biological staging of Alzheimer's disease.用于阿尔茨海默病生物学分期的血浆tau生物标志物。
Nat Aging. 2025 Aug 22. doi: 10.1038/s43587-025-00951-w.
2
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.基于生物标志物的阿尔茨海默病分期:原理与临床应用。
Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1.
3
Incorporating Acute Conditions into Risk-Adjustment for Provider Profiling: The Case of the US News and World Report Best Hospitals Rankings Methodology.
将急性病纳入提供者画像的风险调整中:以《美国新闻与世界报道》最佳医院排名方法为例。
Am J Med Qual. 2024;39(2):69-77. doi: 10.1097/JMQ.0000000000000171. Epub 2024 Feb 19.
4
Developing a Staging Scheme for Essential Tremor: A Discussion of Organizing Principles.制定特发性震颤分期方案:组织原则探讨。
Tremor Other Hyperkinet Mov (N Y). 2023 Nov 7;13:43. doi: 10.5334/tohm.812. eCollection 2023.
5
Biomarker modeling of Alzheimer's disease using PET-based Braak staging.使用基于 PET 的 Braak 分期对阿尔茨海默病的生物标志物建模。
Nat Aging. 2022 Jun;2(6):526-535. doi: 10.1038/s43587-022-00204-0. Epub 2022 Apr 25.
6
The Nursing Home Severity Index and Application to Pressure Injury Risk: Measure Development and Validation Study.养老院严重程度指数及其在压力性损伤风险评估中的应用:测量指标的开发与验证研究
JMIR Aging. 2023 Feb 9;6:e43130. doi: 10.2196/43130.
7
Idiopathic Pulmonary Fibrosis Mortality Risk Prediction Based on Artificial Intelligence: The CTPF Model.基于人工智能的特发性肺纤维化死亡风险预测:CTPF模型
Front Pharmacol. 2022 Apr 26;13:878764. doi: 10.3389/fphar.2022.878764. eCollection 2022.
8
Present status and future directions of intracanal medicaments.根管内药物的现状与未来方向。
Int Endod J. 2022 May;55 Suppl 3(Suppl 3):613-636. doi: 10.1111/iej.13731. Epub 2022 Apr 19.
9
Physiomimetic Models of Adenomyosis.腺肌病的拟生理模型。
Semin Reprod Med. 2020 May;38(2-03):179-196. doi: 10.1055/s-0040-1719084. Epub 2020 Nov 9.
10
Transdiagnostic clinical staging in youth mental health: a first international consensus statement.青少年心理健康的跨诊断临床分期:首份国际共识声明。
World Psychiatry. 2020 Jun;19(2):233-242. doi: 10.1002/wps.20745.